FASEB J. Integrated DNA Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-128116.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-128116v1
23/8/2681    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishijo, K.
Right arrow Articles by Keller, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishijo, K.
Right arrow Articles by Keller, C.
(The FASEB Journal. 2009;23:2681-2690.)
© 2009 FASEB

Biomarker system for studying muscle, stem cells, and cancer in vivo

Koichi Nishijo*, Tohru Hosoyama*, Christopher R. R. Bjornson{dagger}, Beverly S. Schaffer*, Suresh I. Prajapati*, Ali N. Bahadur*, Mark S. Hansen{ddagger}, Mary C. Blandford{ddagger}, Amanda T. McCleish*, Brian P. Rubin§, Jonathan A. Epstein||, Thomas A. Rando{dagger}, Mario R. Capecchi{ddagger} and Charles Keller*,1

* Greehey Children’s Cancer Research Institute and Departments of Cellular and Structural Biology and Pediatrics, University of Texas Health Science Center, San Antonio, Texas, USA;

{dagger} Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California, USA;

{ddagger} Department of Human Genetics, University of Utah, Salt Lake City, Utah, USA;

§ Departments of Anatomic Pathology and Molecular Genetics, Taussig Cancer Center and Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA; and

|| Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA

1 Correspondence: 8403 Floyd Curl Dr., MC-7784, San Antonio, TX 78229-3900, USA. E-mail: kellerc2{at}uthscsa.edu

Bioluminescent reporter genes are sensitive in situ tools for following disease progression in preclinical models, albeit they are subject to scattering and absorption in deep tissues. We have generated a bicistronic Cre/LoxP reporter mouse line that pairs the expression of firefly luciferase with quantifiable expression of a human placental alkaline phosphatase that is secreted into the serum (SeAP). With the use of this dual-modality bioreporter with a novel, inducible Pax7-CreER line for tracking muscle satellite cells, we demonstrate the longitudinal kinetics of muscle stem cell turnover, accounting for a doubling of the signal from satellite cell and progeny every 3.93 wk in the transition from adolescence to early adulthood. We also show that this dual-modality bioreporter can be incorporated in preclinical cancer models, whereby SeAP activity is reflective of tumor burden. Thus, this dual bioreporter permits both spatial localization and accurate quantification of biological processes in vivo even when the tissue of interest is deep within the animal.—Nishijo, K., Hosoyama, T., Bjornson, C. R. R., Schaffer, B. S., Prajapati, S. I., Bahadur, A. N., Hansen, M. S., Blandford, M. C., McCleish, A. T., Rubin, B. P., Epstein, J. A., Rando, T. A., Capecchi, M. R., Keller, C. Biomarker system for studying muscle, stem cells, and cancer in vivo.


Key Words: optical imaging • reporter gene • satellite cell







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.